用于治疗多发性硬化症的抗整合素疗法。
Anti-integrin therapy for multiple sclerosis.
作者信息
Kawamoto Eiji, Nakahashi Susumu, Okamoto Takayuki, Imai Hiroshi, Shimaoka Motomu
机构信息
Emergency and Critical Care Center, Mie University Hospital, 2-174 Edobashi, Tsu 514-8507, Japan.
出版信息
Autoimmune Dis. 2012;2012:357101. doi: 10.1155/2012/357101. Epub 2012 Dec 17.
Abstract
Integrins are the foremost family of cell adhesion molecules that regulate immune cell trafficking in health and diseases. Integrin alpha4 mediates organ-specific migration of immune cells to the inflamed brain, thereby playing the critical role in the pathogenesis of multiple sclerosis. Anti-alpha4 integrin therapy aiming to block infiltration of autoreactive lymphocytes to the inflamed brain has been validated in several clinical trials for the treatment of multiple sclerosis. This paper provides readers with an overview of the molecular and structural bases of integrin activation as well as rationale for using anti-alpha4 integrin therapy for multiple sclerosis and then chronicles the rise and fall of this treatment strategy using natalizumab, a humanized anti-alpha4 integrin.
摘要
整合素是调节健康和疾病状态下免疫细胞迁移的首要细胞黏附分子家族。整合素α4介导免疫细胞向炎症大脑的器官特异性迁移，从而在多发性硬化症的发病机制中发挥关键作用。旨在阻止自身反应性淋巴细胞浸润到炎症大脑的抗α4整合素疗法已在多项治疗多发性硬化症的临床试验中得到验证。本文为读者提供了整合素激活的分子和结构基础概述，以及使用抗α4整合素疗法治疗多发性硬化症的理论依据，然后记述了使用人源化抗α4整合素那他珠单抗的这一治疗策略的兴衰。
相似文献
1
Anti-integrin therapy for multiple sclerosis.用于治疗多发性硬化症的抗整合素疗法。
Autoimmune Dis. 2012;2012:357101. doi: 10.1155/2012/357101. Epub 2012 Dec 17.
2
Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale.抗α4整合素疗法治疗多发性硬化症：作用机制与理论依据
Neurology. 2005 Apr 26;64(8):1336-42. doi: 10.1212/01.WNL.0000158329.30470.D0.
3
Novel treatment options for inflammatory bowel disease: targeting alpha 4 integrin.炎症性肠病的新型治疗选择：靶向α4整合素
Drugs. 2006;66(9):1179-89. doi: 10.2165/00003495-200666090-00002.
4
Evaluation of the anti-HIV activity of natalizumab, an antibody against integrin alpha4.评估那他珠单抗（一种抗整合素α4抗体）的抗HIV活性。
AIDS. 2009 Jan 14;23(2):266-8. doi: 10.1097/qad.0b013e328320a7f8.
5
Development of α4 integrin DNA aptamer as a potential therapeutic tool for multiple sclerosis.开发α4 整合素 DNA 适体作为多发性硬化症的潜在治疗工具。
J Cell Biochem. 2019 Sep;120(9):16264-16272. doi: 10.1002/jcb.28907. Epub 2019 May 20.
6
Natalizumab: AN 100226, anti-4alpha integrin monoclonal antibody.那他珠单抗：AN 100226，抗4α整合素单克隆抗体。
Drugs R D. 2004;5(2):102-7. doi: 10.2165/00126839-200405020-00007.
7
Natalizumab for induction of remission in Crohn's disease.那他珠单抗用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2007 Jan 24(1):CD006097. doi: 10.1002/14651858.CD006097.pub2.
8
Natalizumab: targeting alpha4-integrins in multiple sclerosis.那他珠单抗：靶向治疗多发性硬化症中的α4整合素
Neurodegener Dis. 2008;5(1):16-22. doi: 10.1159/000109933.
9
Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment.黏附分子是建立那他珠单抗治疗替代标志物的有前途的候选物。
Mult Scler. 2011 Jan;17(1):16-23. doi: 10.1177/1352458510383075. Epub 2010 Oct 11.
10
The role of α4 integrin in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease: an infectious animal model for multiple sclerosis (MS).α4整合素在泰勒氏鼠脑脊髓炎病毒（TMEV）诱导的脱髓鞘疾病中的作用：一种多发性硬化症（MS）的感染性动物模型
Int Immunol. 2016 Dec;28(12):575-584. doi: 10.1093/intimm/dxw045. Epub 2016 Nov 1.
引用本文的文献
1
The motor-clutch model in mechanobiology and mechanomedicine.力学生物学与机械医学中的运动-离合器模型
Mechanobiol Med. 2024 Apr 3;2(3):100067. doi: 10.1016/j.mbm.2024.100067. eCollection 2024 Sep.
2
Integrins as Drug Targets in Vascular and Related Diseases.整合素作为血管及相关疾病的药物靶点
Int J Drug Discov Pharm. 2024 Jun;3(2). doi: 10.53941/ijddp.2024.100010. Epub 2024 Jun 21.
3
Anti-CD49d Ab treatment ameliorates age-associated inflammatory response and mitigates CD8 T-cell cytotoxicity after traumatic brain injury.抗 CD49dAb 治疗可改善创伤性脑损伤后与年龄相关的炎症反应，并减轻 CD8+T 细胞的细胞毒性。
J Neuroinflammation. 2024 Oct 19;21(1):267. doi: 10.1186/s12974-024-03257-7.
4
Eosinophil: An innate immune cell with anti-filarial vaccine and biomarker potential.嗜酸性粒细胞：一种具有抗丝虫疫苗和生物标志物潜力的固有免疫细胞。
Health Sci Rep. 2023 Jun 5;6(6):e1320. doi: 10.1002/hsr2.1320. eCollection 2023 Jun.
5
Assessing a computational pipeline to identify binding motifs to the 21 integrin.评估一种计算流程以识别与α2β1整合素结合的基序。
Front Chem. 2023 Feb 13;11:1107400. doi: 10.3389/fchem.2023.1107400. eCollection 2023.
6
Targeting integrin pathways: mechanisms and advances in therapy.靶向整合素途径：机制与治疗进展。
Signal Transduct Target Ther. 2023 Jan 2;8(1):1. doi: 10.1038/s41392-022-01259-6.
7
A comprehensive review of intravitreal immunosuppressants and biologicals used in ophthalmology.眼科玻璃体内使用的免疫抑制剂和生物制剂的综合综述。
Ther Adv Ophthalmol. 2022 May 18;14:25158414221097418. doi: 10.1177/25158414221097418. eCollection 2022 Jan-Dec.
8
Integrin Regulated Autoimmune Disorders: Understanding the Role of Mechanical Force in Autoimmunity.整合素调节的自身免疫性疾病：理解机械力在自身免疫中的作用
Front Cell Dev Biol. 2022 Mar 18;10:852878. doi: 10.3389/fcell.2022.852878. eCollection 2022.
9
Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab.评估血液生物标志物以确定那他珠单抗的治疗窗。
J Pers Med. 2021 Dec 10;11(12):1347. doi: 10.3390/jpm11121347.
10
The Spike Glycoprotein of SARS-CoV-2 Binds to β1 Integrins Expressed on the Surface of Lung Epithelial Cells.SARS-CoV-2 的刺突糖蛋白与肺上皮细胞表面表达的β1 整合素结合。
Viruses. 2021 Apr 9;13(4):645. doi: 10.3390/v13040645.
本文引用的文献
1
Natalizumab: bench to bedside and beyond.那他珠单抗：从实验室到临床应用及更多。
JAMA Neurol. 2013 Feb;70(2):172-82. doi: 10.1001/jamaneurol.2013.598.
2
Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo.周细胞支持中性粒细胞在内皮细胞下的爬行和活体静脉壁的突破。
J Exp Med. 2012 Jun 4;209(6):1219-34. doi: 10.1084/jem.20111622. Epub 2012 May 21.
3
Risk of natalizumab-associated progressive multifocal leukoencephalopathy.纳武利尤单抗相关进行性多灶性白质脑病的风险。
N Engl J Med. 2012 May 17;366(20):1870-80. doi: 10.1056/NEJMoa1107829.
4
Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial.非奈利特治疗复发缓解型多发性硬化症：一项 2 期、随机、双盲、安慰剂对照试验。
Lancet Neurol. 2012 Feb;11(2):131-9. doi: 10.1016/S1474-4422(11)70299-X. Epub 2012 Jan 5.
5
Regulation of integrin activation.整合素激活的调控。
Annu Rev Cell Dev Biol. 2011;27:321-45. doi: 10.1146/annurev-cellbio-100109-104104. Epub 2011 Jun 10.
6
Recommendations for the selection, treatment, and management of patients utilizing natalizumab therapy for multiple sclerosis.多发性硬化症患者使用那他珠单抗治疗的选择、治疗和管理建议。
Am J Manag Care. 2010 Jun;16(6 Suppl):S178-83.
7
Economic burden of multiple sclerosis: a systematic review of the literature.多发性硬化症的经济负担：文献系统综述。
Pharmacoeconomics. 2010;28(5):363-79. doi: 10.2165/11532230-000000000-00000.
8
Essential roles of VLA-4 in the hematopoietic system.VLA-4 在造血系统中的基本作用。
Int J Hematol. 2010 May;91(4):569-75. doi: 10.1007/s12185-010-0555-3. Epub 2010 Mar 30.
9
Distinct roles for LFA-1 affinity regulation during T-cell adhesion, diapedesis, and interstitial migration in lymph nodes.LFA-1 亲和力调节在 T 细胞黏附、渗出和淋巴结间质迁移中的不同作用。
Blood. 2010 Feb 25;115(8):1572-81. doi: 10.1182/blood-2009-08-237917. Epub 2009 Dec 18.
10
How Tysabri survived.特立氟胺是如何起死回生的。
Nat Biotechnol. 2009 Nov;27(11):986. doi: 10.1038/nbt1109-986.
Zotero 插件